INVO Bioscience Inc
NASDAQ:INVO
INVO Bioscience Inc
NASDAQ:INVO
Price:
0.98 USD
-0.01%
Market Closed
Updated:
Apr 29, 2024
Section:
Relative Value
The Relative Value of one
INVO
stock under the Base Case scenario is
44.68
USD.
Compared to the current market price of 0.98 USD,
INVO Bioscience Inc
is
Undervalued by 98%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
INVO
Relative Value
Base Case
44.68
USD
Undervaluation 98%
Valuation Multiples
Multiples Across Competitors
INVO Competitors Multiples
INVO Bioscience Inc Competitors
INVO Bioscience Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
INVO Bioscience Inc
NASDAQ:INVO
|
2.4m USD | 0.8 | -0.3 | -0.7 | -0.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.5B USD | 4.6 | 33.1 | 19.5 | 29 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
133.1B USD | 18.2 | 67 | 54.9 | 68.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.6B USD | 6.2 | 40.3 | 25.1 | 31.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
107.2B USD | 7.5 | 68.3 | 31.7 | 47.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106B USD | 3.3 | 25.2 | 13.5 | 19.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
66.9B USD | 3.4 | 54.9 | 18.4 | 38.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.1B EUR | 2.7 | 38.9 | 18.6 | 31.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 8.7 | 37 | 26.8 | 29 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
47.9B USD | 13.2 | 88.5 | 59.6 | 77.6 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
349.3B CNY | 10.2 | 30.8 | 26.7 | 26.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
